← Leaderboards
Martin Marsala
University Of California San Diego
$11,581,323
Attributed
$17,346,603
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,346,603 · 8
By mechanism
R01$17,346,603 · 8
Top collaborators
- Don W. Cleveland10 shared
- Sandrine Da Cruz5 shared
- Clotilde Lagier-Tourenne5 shared
- Samuel L. Pfaff4 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Brett C Meyer$5,420,863
- Jeff M Hasty$24,639,672
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMotor NeuronsCellsNeuronsSpinal Cord InjuryGene ExpressionGeneticSpinal CordMuscleProteinsAmyotrophic Lateral SclerosisInheritedMutationMediatingMaintenanceSpinalAnimalsDesignTransgenic OrganismsResearch StudyPropertyRepairedStem CellsDementia
Grant awards (36)
Spinal Subpial Gene Delivery for Treatment of Amyotrophic Lateral Sclerosis$636,840
R01 · FY2025 · NS · contact PI
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$839,174
R01 · FY2024 · NS
Spinal Subpial Gene Delivery for Treatment of Amyotrophic Lateral Sclerosis$617,646
R01 · FY2024 · NS · contact PI
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$853,797
R01 · FY2023 · NS
Spinal Subpial Gene Delivery for Treatment of Amyotrophic Lateral Sclerosis$636,662
R01 · FY2023 · NS · contact PI
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$797,269
R01 · FY2022 · NS
Spinal Subpial Gene Delivery for Treatment of Amyotrophic Lateral Sclerosis$656,020
R01 · FY2022 · NS · contact PI
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$798,489
R01 · FY2021 · NS
Disease mechanism in ALS and frontotemporal dementia$647,454
R01 · FY2021 · NS
Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$826,652
R01 · FY2020 · NS
Disease mechanism in ALS and frontotemporal dementia$647,454
R01 · FY2020 · NS
Disease mechanism in ALS and frontotemporal dementia$647,454
R01 · FY2019 · NS
Disease mechanism in ALS and frontotemporal dementia$647,454
R01 · FY2018 · NS
Modulation of spinal neurodegenerative diseases in swine by stem cell grafting$511,469
R01 · FY2018 · OD · contact PI
Disease mechanism in ALS and frontotemporal dementia$661,854
R01 · FY2017 · NS
Modulation of spinal neurodegenerative diseases in swine by stem cell grafting$485,807
R01 · FY2017 · OD · contact PI
Modulation of spinal neurodegenerative diseases in swine by stem cell grafting$511,286
R01 · FY2016 · OD · contact PI
Transgenic mice and bioinformatic tools to track astrocyte diversification insitu$443,944
R01 · FY2016 · MH
Modulation of spinal neurodegenerative diseases in swine by stem cell grafting$511,254
R01 · FY2015 · OD · contact PI
Transgenic mice and bioinformatic tools to track astrocyte diversification insitu$444,887
R01 · FY2015 · MH
Transgenic mice and bioinformatic tools to track astrocyte diversification insitu$397,303
R01 · FY2014 · MH
Transgenic mice and bioinformatic tools to track astrocyte diversification insitu$421,692
R01 · FY2013 · MH
Ischemic Spasticity: Modulation by GAD65 Gene Delivery$410,434
R01 · FY2010 · NS · contact PI
Ischemic Spasticity: Modulation by GAD65 Gene Delivery$337,544
R01 · FY2009 · NS · contact PI
Ischemic Spasticity: Modulation by GAD65 Gene Delivery$76,447
R01 · FY2009 · NS · contact PI
Ischemic Spasticity: Modulation by GAD65 Gene Delivery$337,544
R01 · FY2008 · NS · contact PI
Ischemic Spasticity: Modulation by GAD65 Gene Delivery$337,544
R01 · FY2007 · NS · contact PI
Ischemic Spasticity: Modulation by GAD65 Gene Delivery$347,438
R01 · FY2006 · NS · contact PI
Ischemic Paraplegia: Modulation by Stem Cell Implant$357,103
R01 · FY2005 · NS
Ischemic Paraplegia: Modulation by Stem Cell Implant$357,103
R01 · FY2004 · NS
Ischemic Paraplegia: Modulation by Stem Cell Implant$346,701
R01 · FY2003 · NS
Ischemic Paraplegia: Modulation by Stem Cell Implant$374,768
R01 · FY2002 · NS
Ischemic Paraplegia: Modulation by Stem Cell Implant$50,000
R01 · FY2002 · NS
SPINAL NEURAL ACTIVITY--ROLE IN POST ISCHEMIC INJURY$175,557
R01 · FY2001 · NS
SPINAL NEURAL ACTIVITY--ROLE IN POST ISCHEMIC INJURY$171,559
R01 · FY2000 · NS
SPINAL NEURAL ACTIVITY--ROLE IN POST ISCHEMIC INJURY$25,000
R01 · FY2000 · NS